Segment Information - Summarized financial information for the Company's segments (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Segment Reporting Information
Consolidated revenue	$ 55,161	$ 48,580
Total segment depreciation expense	314	165
Total segment amortization	673	612
Selling, general and administrative expense	29,806	11,178
Non-segment depreciation and amortization	987	777
Loss from operations	(18,471)	(1,753)
Operating segments
Segment Reporting Information
Consolidated revenue	55,161	48,580
Total segment direct costs	42,839	38,378
Total segment depreciation expense	297	156
Total segment amortization	674	613
Total segment operating income	11,351	9,433
Selling, general and administrative expense	29,806	11,178
Non-segment assets
Segment Reporting Information
Non-segment depreciation and amortization	16	8
Patient services | Operating segments
Segment Reporting Information
Consolidated revenue	35,057	29,622
Total segment direct costs	27,378	23,086
Total segment depreciation expense	250	127
Total segment amortization	621	560
Total segment operating income	6,808	5,849
Dispensary | Operating segments
Segment Reporting Information
Consolidated revenue	18,679	17,618
Total segment direct costs	15,324	15,123
Total segment depreciation expense	0	0
Total segment amortization	0	0
Total segment operating income	3,355	2,495
Clinical trials & other | Operating segments
Segment Reporting Information
Consolidated revenue	1,425	1,340
Total segment direct costs	137	169
Total segment depreciation expense	47	29
Total segment amortization	53	53
Total segment operating income	$ 1,188	$ 1,089